全文获取类型
收费全文 | 2217篇 |
免费 | 182篇 |
国内免费 | 12篇 |
专业分类
耳鼻咽喉 | 21篇 |
儿科学 | 61篇 |
妇产科学 | 35篇 |
基础医学 | 253篇 |
口腔科学 | 40篇 |
临床医学 | 255篇 |
内科学 | 371篇 |
皮肤病学 | 22篇 |
神经病学 | 181篇 |
特种医学 | 179篇 |
外国民族医学 | 1篇 |
外科学 | 382篇 |
综合类 | 94篇 |
一般理论 | 1篇 |
预防医学 | 200篇 |
眼科学 | 12篇 |
药学 | 211篇 |
中国医学 | 1篇 |
肿瘤学 | 91篇 |
出版年
2021年 | 40篇 |
2020年 | 19篇 |
2019年 | 33篇 |
2018年 | 40篇 |
2017年 | 40篇 |
2016年 | 27篇 |
2015年 | 26篇 |
2014年 | 41篇 |
2013年 | 70篇 |
2012年 | 98篇 |
2011年 | 99篇 |
2010年 | 70篇 |
2009年 | 48篇 |
2008年 | 84篇 |
2007年 | 95篇 |
2006年 | 93篇 |
2005年 | 83篇 |
2004年 | 83篇 |
2003年 | 78篇 |
2002年 | 53篇 |
2001年 | 57篇 |
2000年 | 88篇 |
1999年 | 59篇 |
1998年 | 39篇 |
1997年 | 45篇 |
1996年 | 33篇 |
1995年 | 38篇 |
1994年 | 29篇 |
1993年 | 29篇 |
1992年 | 46篇 |
1991年 | 68篇 |
1990年 | 55篇 |
1989年 | 52篇 |
1988年 | 59篇 |
1987年 | 49篇 |
1986年 | 51篇 |
1985年 | 31篇 |
1984年 | 36篇 |
1983年 | 24篇 |
1982年 | 17篇 |
1981年 | 16篇 |
1980年 | 21篇 |
1979年 | 16篇 |
1978年 | 19篇 |
1977年 | 17篇 |
1976年 | 16篇 |
1975年 | 23篇 |
1974年 | 14篇 |
1972年 | 17篇 |
1968年 | 14篇 |
排序方式: 共有2411条查询结果,搜索用时 15 毫秒
71.
Amanda Jensen-Doss Leticia D. Osterberg J. Scott Hickey Tia Crossley 《Administration and policy in mental health》2013,40(5):428-437
Rating scales are useful for evidence-based assessment of youth psychopathology. However, it is not known whether these scales contribute information beyond that which clinicians gather without them. This study examined agreement between chart diagnoses and the Child Behavior Checklist (CBCL) for 82 community mental health clinic clients. Agreement was low, suggesting that the CBCL was not redundant with clinicians’ clinical impressions. These findings suggest that use of an instrument like the CBCL could potentially improve clinician diagnostic accuracy; future research should examine how best to utilize these scales in the diagnostic process and how to train clinicians in their use. 相似文献
72.
Ahmed Gabr Joseph Ralph Kallini Vanessa L. Gates Ryan Hickey Laura Kulik Kush Desai Bartley Thornburg Karen Marshall Krystina Salzig Melissa Williams Carlene del Castillo Daniel Ganger Elias Hohlastos Talia Baker Robert J. Lewandowski Riad Salem 《European journal of nuclear medicine and molecular imaging》2016,43(13):2353-2359
Purpose
To assess the feasibility of conducting pretreatment mesenteric angiography, coil embolization, 99mTc macroaggregated albumin (99mTc-MAA) scintigraphy, and 90Y radioembolization treatment in a single, same-day, combined outpatient encounter.Methods
This was a retrospective study of 78 patients treated during the period 2008 – 2015 who were managed in a single outpatient encounter under the guidance of the Interventional Radiology Department and The Nuclear Medicine Department. Pretreatment planning was performed by reviewing baseline imaging and estimated perfused liver volume bearing the tumor. The region of interest was estimated using 3-D software; this value was used for dosimetry planning. Maximum lung shunting fractions of 10 % for hepatocellular carcinoma and 5 % for liver metastases were assumed. Subsequently, hepatic angiography and 99mTc-MAA scintigraphy were performed followed by 90Y treatment in one outpatient encounter. Total in-room procedure time was recorded.Results
All patients underwent same-day angiography, 99mTc-MAA scintigraphy and 90Y radioembolization. Of the 78 patients, 16 received multiple segmental treatments to both lobes, 44 received treatment to the right lobe, and 18 received treatment to the left lobe. The median dose was 106 Gy. The median number of 90Y vials needed was two (range one to six). The median in-room time was 160 min (75 – 250 min). The residential status of the patients was as follows, 18 % (14/78) were local residents, 55 % (43/78) traveled from outside the city limits, 18 % (14/78) were from out-of-state, and 9 % (7/78) were resident abroad. Of the 78 patients, 61 (77 %) had hepatocellular carcinoma, and 17 (22 %) had liver metastases. The median lung dose was 3.5 Gy.Conclusion
This study demonstrated the feasibility of same-day 90Y evaluation and treatment while maintaining the principles of safe and effective 90Y infusion including tumoricidal dosimetry (lobar, segmentectomy), minimization of nontarget flow, and minimization of lung dose. This paradigm translates into expeditious cancer care and significant cost savings.73.
Increasing numbers of women are requesting non-hormonal treatments for menopausal symptoms. Estrogen-containing HRT is the most effective treatment for menopausal symptoms in healthy women but is contraindicated for some women and avoided by many others. This review will assess the evidence regarding the safety and efficacy of non-hormonal treatments for menopausal symptoms. Relatively few high quality studies have addressed this issue, almost all have only addressed the treatment of hot flushes and there are few long-term data. 相似文献
74.
Ashaben Patel Vineet Gupta John Hickey Nancy S. Nightlinger Richard S. Rogers Christine Siska Sangeeta B. Joshi Michael S. Seaman David B. Volkin Bruce A. Kerwin 《Journal of pharmaceutical sciences》2018,107(12):3032-3046
In this study, we investigated analytical challenges associated with the formulation of 2 anti-HIV broadly neutralizing antibodies (bnAbs), 3BNC117 and PGT121, both separately at 100 mg/mL and together at 50 mg/mL each. The bnAb formulations were characterized for relative solubility and conformational stability followed by accelerated and real-time stability studies. Although the bnAbs were stable during 4°C storage, incubation at 40°C differentiated their stability profiles. Specific concentration-dependent aggregation rates at 30°C and 40°C were measured by size exclusion chromatography for the individual bnAbs with the mixture showing intermediate behavior. Interestingly, although the relative ratio of the 2 bnAbs remained constant at 4°C, the ratio of 3BNC117 to PGT121 increased in the dimer that formed during storage at 40°C. A mass spectrometry-based multiattribute method, identified and quantified differences in modifications of the Fab regions for each bnAb within the mixture including clipping, oxidation, deamidation, and isomerization sites. Each bnAb showed slight differences in the levels and sites of lysine residue glycations. Together, these data demonstrate the ability to differentiate degradation products from individual antibodies within the bnAb mixture, and that degradation rates are influenced not only by the individual bnAb concentrations but also by the mixture concentration. 相似文献
75.
Ying Wan John M. Hickey Christopher Bird Katey Witham Paul Fahey Angus Forster Sangeeta B. Joshi David B. Volkin 《Journal of pharmaceutical sciences》2018,107(6):1540-1551
The worldwide switch to inactivated polio vaccines (IPVs) is a key component of the overall strategy to achieve and maintain global polio eradication. To this end, new IPV vaccine delivery systems may enhance patient convenience and compliance. In this work, we examine Nanopatch? (a solid, polymer microprojection array) which offers potential advantages over standard needle/syringe administration including intradermal delivery and reduced antigen doses. Using trivalent IPV (tIPV) and a purpose-built evaporative dry-down system, candidate tIPV formulations were developed to stabilize tIPV during the drying process and on storage. Identifying conditions to minimize tIPV potency losses during rehydration and potency testing was a critical first step. Various classes and types of pharmaceutical excipients (~50 total) were then evaluated to mitigate potency losses (measured through D-antigen ELISAs for IPV1, IPV2, and IPV3) during drying and storage. Various concentrations and combinations of stabilizing additives were optimized in terms of tIPV potency retention, and 2 candidate tIPV formulations containing cyclodextrin and a reducing agent (e.g., glutathione), maintained ≥80% D-antigen potency during drying and subsequent storage for 4 weeks at 4°C, and ≥60% potency for 3 weeks at room temperature with the majority of losses occurring within the first day of storage. 相似文献
76.
77.
78.
79.
80.
Sara Montminy Paquette Had Dawit Magali B. Hickey Elaine Merisko-Liversidge Örn Almarsson Daniel R. Deaver 《Pharmaceutical research》2014,31(8):2065-2077